secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001641172-25-002147
Event type: other
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals provides Nasdaq compliance update; equity above $2.5M threshold
--------------------------------------------------------------------------------

- Submitted pro-forma financials showing Stockholder's Equity of $2.8M as of March 31, 2025, above Nasdaq's $2.5M minimum.
- Currently compliant with Market Value of Publicly Held Securities standard (>$1.0M).
- Application to transfer to Nasdaq Capital Market was made on March 7, 2025.
- CEO David Tapolczay signed the report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225002147/0001641172-25-002147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225002147/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer